Messerli FH - Search Results

1

Left ventricular hypertrophy. A cardiovascular risk factor in essential hypertension.

Messerli FH, Schmieder R. Messerli FH, et al. Drugs. 1986;31 Suppl 4:192-201. doi: 10.2165/00003495-198600314-00023. Drugs. 1986. PMID: 2942387 Review.

2

Reversal of left ventricular hypertrophy: a desirable therapeutic goal?

Schmieder RE, Messerli FH. Schmieder RE, et al. Among authors: messerli fh. J Cardiovasc Pharmacol. 1990;16 Suppl 6:S16-22. J Cardiovasc Pharmacol. 1990. PMID: 1707110 Review.

3

A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension.

Klingbeil AU, Schneider M, Martus P, Messerli FH, Schmieder RE. Klingbeil AU, et al. Among authors: messerli fh. Am J Med. 2003 Jul;115(1):41-6. doi: 10.1016/s0002-9343(03)00158-x. Am J Med. 2003. PMID: 12867233 Review.

4

Hemodynamic, humoral and volume findings in systemic hypertension with isolated ventricular septal hypertrophy.

Schmieder RE, Messerli FH, Nunez BD, Garavaglia GE, Frohlich ED. Schmieder RE, et al. Among authors: messerli fh. Am J Cardiol. 1988 Nov 15;62(16):1053-7. doi: 10.1016/0002-9149(88)90547-4. Am J Cardiol. 1988. PMID: 2973218

5

Does the renin-angiotensin-aldosterone system modify cardiac structure and function in essential hypertension?

Schmieder RE, Messerli FH, Garavaglia GE, Nunez B, MacPhee AA, Re RN. Schmieder RE, et al. Among authors: messerli fh. Am J Med. 1988 Mar 11;84(3A):136-9. doi: 10.1016/0002-9343(88)90220-3. Am J Med. 1988. PMID: 2975463

6

Sodium intake modulates left ventricular hypertrophy in essential hypertension.

Schmieder RE, Messerli FH, Rüddel H, Garavaglia GG, Grube E, Nunez BD, Schulte W. Schmieder RE, et al. Among authors: messerli fh. J Hypertens Suppl. 1988 Dec;6(4):S148-50. doi: 10.1097/00004872-198812040-00043. J Hypertens Suppl. 1988. PMID: 2977158

7

Antihypertensive therapy and cardiovascular reactivity during isometric stress.

Garavaglia GE, Messerli FH, Schmieder RE, Nunez BD. Garavaglia GE, et al. Among authors: messerli fh. J Hum Hypertens. 1988 Dec;2(4):247-51. J Hum Hypertens. 1988. PMID: 3236326

8

Obesity hypertension.

Schmieder RE, Messerli FH. Schmieder RE, et al. Among authors: messerli fh. Med Clin North Am. 1987 Sep;71(5):991-1001. doi: 10.1016/s0025-7125(16)30822-7. Med Clin North Am. 1987. PMID: 3306213 Review.

9

Heterogeneous pathophysiology of essential hypertension: implications for therapy.

Messerli FH, Schmieder RE, Nunez BD. Messerli FH, et al. Am Heart J. 1986 Oct;112(4):886-93. doi: 10.1016/0002-8703(86)90498-9. Am Heart J. 1986. PMID: 3532746 Review. No abstract available.

10

Cardiovascular effects of verapamil in patients with essential hypertension.

Schmieder RE, Messerli FH, Garavaglia GE, Nunez BD. Schmieder RE, et al. Among authors: messerli fh. Circulation. 1987 May;75(5):1030-6. doi: 10.1161/01.cir.75.5.1030. Circulation. 1987. PMID: 3568303

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

773 results

Search Page

Filters